Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Bio-Therapeutic Glycoproteins are bioactive compounds with carbohydrates attached to proteins. Glycan is the specific site where carbohydrate attaches to proteins and process of production is called glycosylation. Bio-therapeutic glycoproteins produced with glycan moieties that are similar to natural mammal glycans. The most common types are glycosylation O-linked and N-linked that are mainly depends on protein sequence attachment. Carbohydrates linked to proteins through either ? and ? linkages. Glycosylation is an important process of bio-therapeutic glycoproteins because it is critically modulated into bioactivity, stability, solubility against proteolysis, yield, clearance rate from circulation and immunogenicity. The bio-therapeutic glycoproteins mainly produced by yeast expression systems, insect cells, mammalian systems, and plant-based expression systems. In yeast expression systems, yeast is cultured chemically to scale up fermentation to an industrial level. Yeast and human share same N-glycan's linkage. Insect cells represent an alternative system for expression of recombinant bio-therapeutic proteins. Later recombinant proteins are separated from insect cells. Mammalian Systems are used to produce complex bio-therapeutic glycoproteins. Most of the FDA approved bio-therapeutic glycoproteins derived from mammalian systems. Plant-based expression systems used for the scale-up production of glycoproteins. Among all systems, mammalian systems are well established in pharmaceuticals. Some examples of bio-therapeutic glycoproteins include tocilizumab, bevacizumab, adalimumab, etc.
The report details the trend, potential and market size of Bio-Therapeutic Glycoproteins market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Bio-Therapeutic Glycoproteinsmarket, defines the market attractiveness level of Bio-Therapeutic Glycoproteins market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Bio-Therapeutic Glycoproteins industry, describes the types of Bio-Therapeutic Glycoproteins market, the applications of major players and the market size, and deeply analyzes the current situation of the global Bio-Therapeutic Glycoproteins market and the development prospects and opportunities of Bio-Therapeutic Glycoproteins industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Bio-Therapeutic Glycoproteins market in Chapter 13.
By Player:
Merck
Abbott Laboratories
Hoffmann-La Roche
Novartis Pharmaceuticals Corp
Genzyme Corp
Amgen
Biogen
Genentech
GlaxoSmithKline
By Type:
Antisera
Cytokines
Clotting Factors
Hormones
Enzymes
Enzyme Inhibitors
By End-User:
Oncology and Haematology
Diabetes
Cardiology
Inflammatory Diseases
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Bio-Therapeutic Glycoproteins Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Bio-Therapeutic Glycoproteins Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Bio-Therapeutic Glycoproteins Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Bio-Therapeutic Glycoproteins Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Bio-Therapeutic Glycoproteins Market Analysis and Outlook to 2022
-
7.1 Global Bio-Therapeutic Glycoproteins Consumption (2017-2022)
-
7.2 United States Bio-Therapeutic Glycoproteins Consumption (2017-2022)
-
7.3 Europe Bio-Therapeutic Glycoproteins Consumption (2017-2022)
-
7.4 China Bio-Therapeutic Glycoproteins Consumption (2017-2022)
-
7.5 Japan Bio-Therapeutic Glycoproteins Consumption (2017-2022)
-
7.6 India Bio-Therapeutic Glycoproteins Consumption (2017-2022)
-
7.7 South Korea Bio-Therapeutic Glycoproteins Consumption (2017-2022)
8 Region and Country-wise Bio-Therapeutic Glycoproteins Market Analysis and Outlook to 2028
-
8.1 Global Bio-Therapeutic Glycoproteins Consumption Forecast (2022-2028)
-
8.2 United States Bio-Therapeutic Glycoproteins Consumption Forecast (2022-2028)
-
8.3 Europe Bio-Therapeutic Glycoproteins Consumption Forecast (2022-2028)
-
8.4 China Bio-Therapeutic Glycoproteins Consumption Forecast (2022-2028)
-
8.5 Japan Bio-Therapeutic Glycoproteins Consumption Forecast (2022-2028)
-
8.6 India Bio-Therapeutic Glycoproteins Consumption Forecast (2022-2028)
-
8.7 South Korea Bio-Therapeutic Glycoproteins Consumption Forecast (2022-2028)
9 Global Bio-Therapeutic Glycoproteins Market Outlook by Types and Applications to 2022
-
9.1 Global Bio-Therapeutic Glycoproteins Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Antisera Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Cytokines Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Clotting Factors Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Hormones Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Enzymes Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Enzyme Inhibitors Consumption and Growth Rate (2017-2022)
-
9.2 Global Bio-Therapeutic Glycoproteins Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Oncology and Haematology Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Diabetes Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Cardiology Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Inflammatory Diseases Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global Bio-Therapeutic Glycoproteins Market Outlook by Types and Applications to 2028
-
10.1 Global Bio-Therapeutic Glycoproteins Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Antisera Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Cytokines Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Clotting Factors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Hormones Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Enzymes Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Enzyme Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Bio-Therapeutic Glycoproteins Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Oncology and Haematology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Cardiology Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Inflammatory Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Bio-Therapeutic Glycoproteins Import and Export Analysis (Top 5 Countries)
-
11.1 Global Bio-Therapeutic Glycoproteins Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Bio-Therapeutic Glycoproteins Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Bio-Therapeutic Glycoproteins Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Bio-Therapeutic Glycoproteins Market Competitive Analysis
-
14.1 Merck
-
14.1.1 Merck Company Details
-
14.1.2 Merck Bio-Therapeutic Glycoproteins Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Merck Bio-Therapeutic Glycoproteins Product and Service
-
14.2 Abbott Laboratories
-
14.2.1 Abbott Laboratories Company Details
-
14.2.2 Abbott Laboratories Bio-Therapeutic Glycoproteins Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Abbott Laboratories Bio-Therapeutic Glycoproteins Product and Service
-
14.3 Hoffmann-La Roche
-
14.3.1 Hoffmann-La Roche Company Details
-
14.3.2 Hoffmann-La Roche Bio-Therapeutic Glycoproteins Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Hoffmann-La Roche Bio-Therapeutic Glycoproteins Product and Service
-
14.4 Novartis Pharmaceuticals Corp
-
14.4.1 Novartis Pharmaceuticals Corp Company Details
-
14.4.2 Novartis Pharmaceuticals Corp Bio-Therapeutic Glycoproteins Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Novartis Pharmaceuticals Corp Bio-Therapeutic Glycoproteins Product and Service
-
14.5 Genzyme Corp
-
14.5.1 Genzyme Corp Company Details
-
14.5.2 Genzyme Corp Bio-Therapeutic Glycoproteins Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Genzyme Corp Bio-Therapeutic Glycoproteins Product and Service
-
14.6 Amgen
-
14.6.1 Amgen Company Details
-
14.6.2 Amgen Bio-Therapeutic Glycoproteins Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Amgen Bio-Therapeutic Glycoproteins Product and Service
-
14.7 Biogen
-
14.7.1 Biogen Company Details
-
14.7.2 Biogen Bio-Therapeutic Glycoproteins Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Biogen Bio-Therapeutic Glycoproteins Product and Service
-
14.8 Genentech
-
14.8.1 Genentech Company Details
-
14.8.2 Genentech Bio-Therapeutic Glycoproteins Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Genentech Bio-Therapeutic Glycoproteins Product and Service
-
14.9 GlaxoSmithKline
-
14.9.1 GlaxoSmithKline Company Details
-
14.9.2 GlaxoSmithKline Bio-Therapeutic Glycoproteins Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 GlaxoSmithKline Bio-Therapeutic Glycoproteins Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Bio-Therapeutic Glycoproteins
-
Figure Bio-Therapeutic Glycoproteins Picture
-
Table Global Bio-Therapeutic Glycoproteins Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Bio-Therapeutic Glycoproteins Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Bio-Therapeutic Glycoproteins Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Bio-Therapeutic Glycoproteins Consumption by Country (2017-2022)
-
Figure United States Bio-Therapeutic Glycoproteins Consumption and Growth Rate (2017-2022)
-
Table Europe Bio-Therapeutic Glycoproteins Consumption and Growth Rate (2017-2022)
-
Figure China Bio-Therapeutic Glycoproteins Consumption and Growth Rate (2017-2022)
-
Figure Japan Bio-Therapeutic Glycoproteins Consumption and Growth Rate (2017-2022)
-
Figure India Bio-Therapeutic Glycoproteins Consumption and Growth Rate (2017-2022)
-
Figure South Korea Bio-Therapeutic Glycoproteins Consumption and Growth Rate (2017-2022)
-
Figure Global Bio-Therapeutic Glycoproteins Consumption Forecast by Country (2022-2028)
-
Figure United States Bio-Therapeutic Glycoproteins Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Bio-Therapeutic Glycoproteins Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Bio-Therapeutic Glycoproteins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Bio-Therapeutic Glycoproteins Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Bio-Therapeutic Glycoproteins Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Bio-Therapeutic Glycoproteins Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antisera Consumption and Growth Rate (2017-2022)
-
Figure Global Cytokines Consumption and Growth Rate (2017-2022)
-
Figure Global Clotting Factors Consumption and Growth Rate (2017-2022)
-
Figure Global Hormones Consumption and Growth Rate (2017-2022)
-
Figure Global Enzymes Consumption and Growth Rate (2017-2022)
-
Figure Global Enzyme Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Oncology and Haematology Consumption and Growth Rate (2017-2022)
-
Figure Global Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiology Consumption and Growth Rate (2017-2022)
-
Figure Global Inflammatory Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Antisera Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cytokines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clotting Factors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hormones Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Enzymes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Enzyme Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oncology and Haematology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiology Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Inflammatory Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Bio-Therapeutic Glycoproteins Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Bio-Therapeutic Glycoproteins Export by Region (Top 5 Countries) (2017-2028)
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Bio-Therapeutic Glycoproteins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Bio-Therapeutic Glycoproteins Product and Service
-
Table Abbott Laboratories (Foundation Year, Company Profile and etc.)
-
Table Abbott Laboratories Bio-Therapeutic Glycoproteins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Bio-Therapeutic Glycoproteins Product and Service
-
Table Hoffmann-La Roche (Foundation Year, Company Profile and etc.)
-
Table Hoffmann-La Roche Bio-Therapeutic Glycoproteins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hoffmann-La Roche Bio-Therapeutic Glycoproteins Product and Service
-
Table Novartis Pharmaceuticals Corp (Foundation Year, Company Profile and etc.)
-
Table Novartis Pharmaceuticals Corp Bio-Therapeutic Glycoproteins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Pharmaceuticals Corp Bio-Therapeutic Glycoproteins Product and Service
-
Table Genzyme Corp (Foundation Year, Company Profile and etc.)
-
Table Genzyme Corp Bio-Therapeutic Glycoproteins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genzyme Corp Bio-Therapeutic Glycoproteins Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Bio-Therapeutic Glycoproteins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Bio-Therapeutic Glycoproteins Product and Service
-
Table Biogen (Foundation Year, Company Profile and etc.)
-
Table Biogen Bio-Therapeutic Glycoproteins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biogen Bio-Therapeutic Glycoproteins Product and Service
-
Table Genentech (Foundation Year, Company Profile and etc.)
-
Table Genentech Bio-Therapeutic Glycoproteins Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genentech Bio-Therapeutic Glycoproteins Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Bio-Therapeutic Glycoproteins Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Bio-Therapeutic Glycoproteins Product and Service
-
